1. Home
  2. LEXX vs STFS Comparison

LEXX vs STFS Comparison

Compare LEXX & STFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEXX
  • STFS
  • Stock Information
  • Founded
  • LEXX 2004
  • STFS 2015
  • Country
  • LEXX Canada
  • STFS China
  • Employees
  • LEXX N/A
  • STFS N/A
  • Industry
  • LEXX Biotechnology: Pharmaceutical Preparations
  • STFS
  • Sector
  • LEXX Health Care
  • STFS
  • Exchange
  • LEXX Nasdaq
  • STFS NYSE
  • Market Cap
  • LEXX 19.6M
  • STFS 16.2M
  • IPO Year
  • LEXX N/A
  • STFS 2024
  • Fundamental
  • Price
  • LEXX $0.95
  • STFS $1.62
  • Analyst Decision
  • LEXX Strong Buy
  • STFS
  • Analyst Count
  • LEXX 1
  • STFS 0
  • Target Price
  • LEXX $5.00
  • STFS N/A
  • AVG Volume (30 Days)
  • LEXX 101.8K
  • STFS 638.3K
  • Earning Date
  • LEXX 07-14-2025
  • STFS 02-14-2025
  • Dividend Yield
  • LEXX N/A
  • STFS N/A
  • EPS Growth
  • LEXX N/A
  • STFS N/A
  • EPS
  • LEXX N/A
  • STFS 0.01
  • Revenue
  • LEXX $615,923.00
  • STFS $16,754,197.00
  • Revenue This Year
  • LEXX $6.04
  • STFS N/A
  • Revenue Next Year
  • LEXX $8.36
  • STFS N/A
  • P/E Ratio
  • LEXX N/A
  • STFS $175.03
  • Revenue Growth
  • LEXX 49.85
  • STFS 75.86
  • 52 Week Low
  • LEXX $0.79
  • STFS $0.80
  • 52 Week High
  • LEXX $4.38
  • STFS $17.91
  • Technical
  • Relative Strength Index (RSI)
  • LEXX 43.10
  • STFS N/A
  • Support Level
  • LEXX $0.79
  • STFS N/A
  • Resistance Level
  • LEXX $0.90
  • STFS N/A
  • Average True Range (ATR)
  • LEXX 0.04
  • STFS 0.00
  • MACD
  • LEXX 0.01
  • STFS 0.00
  • Stochastic Oscillator
  • LEXX 60.87
  • STFS 0.00

About LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.

About STFS STAR FASHION CULTURE HOLDINGS LIMITED

Star Fashion Culture Holdings Ltd is a content marketing solutions services provider. The company offer services focusing on marketing campaign planning and execution, offline advertising services; and online precision marketing services. The services also include marketing campaign planning and execution, events including marathons, sports events, and music festivals.

Share on Social Networks: